Prevention of hearing loss by CRISPR correction of the Mir96+14C>A mutation has recently been demonstrated to be effective in mice [55], but in vivo gene editing to treat hearing impairment has yet to be implemented in humans and requires precise knowledge of the underlying genetic pathology. This evidence concerns the gene MIR96 and hearing loss disorder.